Furthermore, TP15-Fc did not directly inhibit proliferation of INA-6, L363 and RPMI-8226 myeloma cells, as well as growth of HUVEC endothelial cells (Supplementary Figure 3, and 4D). This evidence concerns the gene CDKN2B and plasma cell myeloma.